Combination drug market declines 56% in March as govt clamps down

Govt has banned over 340 FDCs and over 900 are under scrutiny

With the government clamping down on combination drugs, the latest market data shows that in March the fixed dose combination (FDC) market declined by 56.4 per cent, when the non-FDC market showed a growth of 9.2 per cent and single molecules grew by 9.4 per cent. 

An FDC drug is one that contains two or more active ingredients in a fixed-dosage ratio. Last year, the government had banned over 340 ‘irrational’ FDCs, which were found to be posing health risks to patients. More FDC drugs are under the scanner at the moment, which may also come under the ban. 

As a result,